Wiley and the European College of Sport Science announce partnership

Beginning January 2024, Wiley will publish the European Journal of Sport Science

2023-06-26

(Press-News.org) HOBOKEN, N.J. – June 26, 2023 – Wiley, a knowledge company and global leader in research, publishing and knowledge solutions, today announced that it will publish the European Journal of Sport Science (EJSS) on behalf of the European College of Sport Science (ECSS) beginning in January 2024, spearheading the journal’s transition to open access.

“EJSS is one of the preeminent multidisciplinary sport science journals,” said Allyn Molina, Vice President for Life Sciences at Wiley. “As a publisher at the forefront of the transition to open access, Wiley looks forward to partnering with ECSS to take EJSS to the next level and establish it as the leading open resource for sport science.”

EJSS publishes the highest caliber scientific research and scholarship in applied sport science; sports and exercise medicine; biomechanics and motor control; physiology and nutrition; and psychology, social science, and humanities. The journal will welcome open access submissions starting in autumn of 2023 and expects to complete the transition to fully open access by January 2024.

“ECSS is delighted to be partnering with Wiley to publish our official journal European Journal of Sport Science,” said ECSS President Professor Jørn Wulff Helge. “We will work closely with Wiley’s expert team to advance the journal, repositioning it as a global open access resource for sport science researchers, practitioners, and anyone with an interest in sport, exercise and health. As a disseminator of high quality, multidisciplinary sport science research, ECSS supports the movement towards an open publishing environment, making research more accessible and discoverable to everyone.”

This new partnership reflects Wiley’s ongoing commitment to the principles and practices of open access. Wiley partners with more professional societies than any other publisher to disseminate scientific knowledge with the fewest possible barriers to access and sharing.

For further information and media enquiries, please contact:
Kate Fullan
Publishing Manager
European College of Sport Science
E kate.fullan@sport-science.org

Sara Henning-Stout
Manager, Article & Journal Publicity
WILEY
P +1 971-429-4230 E newsroom@wiley.com

ABOUT WILEY
Wiley is a knowledge company, a global leader in research, publishing, and knowledge solutions. One of the world’s largest publishers, Wiley is dedicated to the creation of knowledge and the application of knowledge in science, learning, and innovation. The company serves the world’s researchers, learners, innovators, and leaders, helping them achieve their goals and solve the world's most important challenges. For more than two centuries, Wiley has been delivering on its timeless mission to unlock human potential. Visit us at Wiley.com. Follow us on Facebook, Twitter, LinkedIn and Instagram.

ABOUT THE EUROPEAN COLLEGE OF SPORT SCIENCE
The European College of Sport Science (ECSS) is a non-profit scientific organization devoted to the promotion and dissemination of multi-and interdisciplinary research in sport, exercise, physical activity and health. Founded in Nice, France in 1995, ECSS has established itself as the leading sport science community in Europe, with a truly international demographic. Find us on Twitter, Facebook, Instagram, LinkedIn and YouTube. Join us at our upcoming congress in Paris, 4-7 July.

END

ELSE PRESS RELEASES FROM THIS DATE:

A potential breakthrough treatment for cystic fibrosis enters clinical trial led by CI Med and U of Iowa researchers

2023-06-26

URBANA, Ill. – Clinical testing is underway for a potentially groundbreaking new treatment for cystic fibrosis. Pioneered by scientists at Carle Illinois College of Medicine at the University of Illinois Urbana-Champaign and the Carver College of Medicine at the University of Iowa in partnership with the spin-out biotechnology company, cystetic Medicines, this promising inhalable molecular prosthetic is intended to improve lung function in people with CF who cannot benefit from current therapies. The launch of this clinical trial is an important ...

Ataxias: International Award for Bonn Patient Care and Research

2023-06-26

The Ataxia Center at the University Hospital Bonn (UKB) and DZNE have been awarded the title “Ataxia Center of Excellence” by the US National Ataxia Foundation (NAF) for their patient care and research – as the only organization in Europe. The foundation represents patient interests and is one of the world’s major non-governmental funders of ataxia research. These rare brain diseases are characterized by progressive loss of balance and coordination, accompanied by slurred speech. It is estimated that this condition affects around 16,000 women and men in Germany. The NAF awarded the title “Ataxia ...

Men experience a long-term drop in semen quality after COVID infection – even if the infection was mild

2023-06-26

Copenhagen, Denmark: More than three months after suffering from mild COVID infection, men have lower sperm concentrations and fewer sperm that are able to swim, according to new findings presented today (Monday) at the 39th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) [1]. Professor Rocio Núñez-Calonge, scientific advisor at UR International Group at the Scientific Reproduction Unit, Madrid (Spain), said that after an average of 100 days following SARS-CoV-2 infection there appeared to be no improvement in sperm quality ...

Cheap and safe hormone treatment shows promise for couples with unexplained infertility

2023-06-26

Copenhagen, Denmark: A small study with couples experiencing unexplained infertility suggests that a hormone treatment could increase the chances of having a baby. The trial, presented today (Monday) at the 39th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) [1], compared couples trying to conceive naturally with couples where the woman used a vaginal progesterone treatment during the second half of her menstrual cycle. The researchers say a larger trial is now warranted but, given the treatment is safe and low-cost, it could ultimately benefit many people living with infertility around the world. The study ...

50-million-year-old katydid fossil reveals muscles, digestive tract, glands and a testicle

2023-06-26

CHAMPAIGN, Ill. — 50 million years ago in what is now northwestern Colorado, a katydid died, sank to the bottom of a lake and was quickly buried in fine sediments, where it remained until its compressed fossil was recovered in recent years. When researchers examined the fossil under a microscope, they saw that not only had many of the insect’s hard structures been preserved in the compressed shale, so had several internal organs and tissues, which are not normally fossilized. They describe their findings in the journal Palaeoentomology. “Katydids ...

Are more babies born if embryos are cultured for three or five days in the lab? Largest randomised clinical trial to date suggests that age matters

2023-06-26

Copenhagen, Denmark: Women are just as likely to give birth to live babies after fertility treatment if embryos are transferred to their wombs three days after fertilisation in the laboratory rather than five. However, the women’s age can affect the outcomes, according to new research presented to the 39th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) [1]. Dr Simone Cornelisse, a researcher and resident in obstetrics and gynaecology at Radboud University Medical Center, Nijmegen (The Netherlands), told the conference that among 1202 women from 21 Dutch fertility centres who were randomly assigned to have embryos transferred to their wombs ...

Cancer risk among women with polycystic ovary syndrome doubles after menopause

2023-06-26

Copenhagen, Denmark: Women with polycystic ovary syndrome (PCOS) are not at any greater risk of ovarian cancer than those without the common hormone condition, say researchers. However, those with PCOS who have been through the menopause are more than twice as likely to be diagnosed with ovarian cancer. The data based on nearly two million women is presented today (Monday) at the 39th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) [1]. The research is also published simultaneously in the International Journal of Cancer [2]. This ...

Humans’ evolutionary relatives butchered one another 1.45 million years ago

2023-06-26

Researchers from the Smithsonian’s National Museum of Natural History have identified the oldest decisive evidence of humans’ close evolutionary relatives butchering and likely eating one another. In a new study published today, June 26, in Scientific Reports, National Museum of Natural History paleoanthropologist Briana Pobiner and her co-authors describe nine cut marks on a 1.45 million-year-old left shin bone from a relative of Homo sapiens found in northern Kenya. Analysis of 3D models of the fossil’s surface revealed ...

Childhood cancer: Vulnerability in the immune response against metastases discovered

2023-06-26

Scientists led by Sabine Taschner-Mandl, PhD, St. Anna Children's Cancer Research Institute, and Nikolaus Fortelny, PhD, Paris Lodron University of Salzburg, are the first to analyze bone marrow metastases from childhood tumors of the nervous system using modern single-cell sequencing analysis. It turns out that cancer cells prevent cells in their environment from fighting the tumor – a process that could be reversed with medication. The findings were published in the renowned journal Nature Communications. Neuroblastoma is the most ...

Novel study deepens knowledge of treatment-resistant hypertension

2023-06-26

For many patients with hypertension—an elevated blood pressure that can lead to stroke or heart attack—medication keeps the condition at bay. But what happens when medication that physicians usually prescribe doesn’t work? Known as apparent resistant hypertension (aRH), this form of high blood pressure requires more medication and medical management. Novel research from investigators in the Smidt Heart Institute at Cedars-Sinai, published today in the peer-reviewed journal Hypertension, found that aRH prevalence was lower in ...

One of the largest studies on preterm birth finds a maternal biomarker test significantly reduces neonatal morbidities and improves neonatal outcomes

One of the largest studies of its kind finds early intervention with iron delivered intravenously during pregnancy is a safe and effective treatment for anemia

Wiley and the European College of Sport Science announce partnership

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: